article thumbnail

FDA’s Issues Draft Guidance on Accelerated Approval: A Substantial Evidentiary and Procedural Overhaul to this High-Profile Pathway

FDA Law Blog

Since that time, it was formalized in FDA regulations (21 CFR 314 Subpart H) in 1992, codified in the Food, Drug, & Cosmetic Act by FDAMA (21 USC 356(c)) in 1997, revised by FDASIA in 2012, and described in guidance, most importantly, in the 2014 Expedited Programs for Serious Conditions Drugs and Biologics (2014 Guidance).

Clinic 64
article thumbnail

News on FDA’s Quality Management Maturity Program-Maturity to Continually Improve and to not be Reactive

FDA Law Blog

In this report, it’s stated that 62% of drug shortages reported between 2012 and 2017 were due to quality issues which is attributed in part to a lack of recognition or reward for manufacturers with mature quality management systems that focus on continuous improvement and early detection of supply chain issues.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Clinical Research Representation: Pass it On

FDA Law Blog

These events marked a turning point in expanding representation in clinical studies and opening the door to more personalized medical care. Since 1993, Congress has continued to direct the federal government, and in particular FDA, to take steps to close the gap in clinical research representation.

Clinic 59
article thumbnail

Does the Drug Shortage White Paper Fall Short?

FDA Law Blog

The White Paper notes that of the 123 drugs in shortage in January 2024, a quarter were first reported in shortage prior to 2020, with the oldest dating back to 2012, and shortages were experienced across therapeutic areas; analgesics/anesthetics (17%), anti-infective (12%), and cardiovascular (13%) products comprised 42% of shortages.

article thumbnail

Gabapentinoids – Gabapentin and Pregabalin: Tasce Bongiovanni, Donovan Maust and Nisha Iyer

GeriPal

There was this big thing called the CMS National Partnership to Improve Dementia Care, started in 2012. I understand that it can be a hard place clinically. We should be able to trust all the data that comes from our governing board. The whole focus was to reduce antipsychotic prescribing. But we should highlight that.

article thumbnail

Once again, the Agency for Healthcare Research and Quality is in the line of fire

Common Sense Family Doctor

Now the Department of Government Efficiency is trying again, threatening 90% staff reductions that would decimate the agency. We make evidence that other groups use to make guidelines"), the passage of the Affordable Care Act made AHRQ a target again in 2012, when a House appropriations subcommittee voted to zero out its budget again.

article thumbnail

Loss of DEI Hurts Everyone: Farah Stockman, Ali Thomas, Ken Covinsky

GeriPal

Now to the federal government that is going way beyond what I think people truly understand. Alex 20:58 Farah, appreciate the medicine metaphor for our clinical audience. So Shalonda Young was the very first black woman to serve as the OMB director in charge of the federal government’s budget. Well played.

IT 70